DNA Synthesis Uncompromised
Fully Enzymatic Synthesis (FES) of DNA
Synthetic DNA is the life force driving discoveries in clinical medicine, pharmaceuticals, agriculture, and food. But the chemical synthesis process we’ve come to rely on only produces short DNA oligos. That’s why we started an enzyme-based DNA synthesis revolution, so you don’t have to choose between fast turnarounds, oligo length, and purity.
Therapeutics/Vaccines
Immunotherapy
Agriculture
Nanotechnology
Applications
Gene Editing
Now AVAILABLE
Design donor template DNA or long guides for a variety of CRISPR edit types including HDR knock-in, prime and base editing
Protein Engineering
NOW AVAILABLE
Long and complex oligos coding for variable regions of antibodies, regulatory elements, or other proteins
Gene Assembly
COMING SOON
Order gene fragments or large genetic constructs with high accuracy regardless of the difficulty of your sequence
Other applications? Consult with our experts to design DNA for your specific project
Benefits
Long
With our proprietary enzymatic synthesis technology, we can produce DNA >150 bases with ease.
Pure
An in-process purification step yields clean DNA without the need for lengthy and expensive post-synthesis purification.
Accelerated
The ability to produce long oligos directly without added purification steps means that we can deliver long, pure DNA faster.
The first Fully Enzymatic Synthesis (FES) technology from pioneers of DNA synthesis
Molecular Assemblies was founded by scientists who helped commercialize the chemical DNA synthesis process. Since then, these same scientists have been working to find a better method. Now, they’ve partnered with leaders in enzyme engineering, Codexis Inc. to provide an evolved terminal deoxynucleotidyl transferase (TdT) at the heart of our Fully Enzymatic Synthesis process.
Evolved polymerase enables accelerated synthesis of long, pure oligos to drive synthetic biology
Featured Events
CRISPR TECHNOLOGIES CONFERENCE
SynBioBeta 2023
Oakland, CA | May 23-25, 2023 Molecular Assemblies is...
